Adversarial Injection · Mancozeb ([ethylenebis(dithiocarbamate)]zinc-manganese complex; CAS 8018-01-7) OSHA PEL 5 mg/m³ TWA [1971 Frozen; AFL-CIO v. OSHA 1992 PEL-Freeze Prevents Update; OSHA 10× Above ACGIH Advisory] / ACGIH TLV-TWA 0.5 mg/m³ A4 SKIN [10× Gap from OSHA PEL; SKIN Notation: ETU Metabolite Systemic Dermal Access; A4 = Not Classifiable; ETU [CAS 96-45-7] Metabolite Is ACGIH A3 + IARC Group 2B Thyroid Follicular Carcinogen] / NIOSH No Specific REL [Enforcement Vacuum for Mancozeb Specifically; NIOSH Ca Applies to ETU Metabolite] / ETU (Ethylene Thiourea; CAS 96-45-7) Thyroid Peroxidase Competitive Inhibitor (Reduced T3/T4; Compensatory TSH Elevation; Thyroid Follicular Hyperplasia → Adenoma → Carcinoma; NTP TR-388 F344/N Rat Thyroid Follicular Carcinoma) / EBDC Zinc-Manganese Dithiocarbamate Polymer / Mancozeb Formulation Manufacturing + Potato Late Blight Prevention Spray + Wine Grape Vineyard Downy Mildew Spray · Attack #361

Mancozeb ([ethylenebis(dithiocarbamate)]zinc-manganese complex; [C₄H₆MnN₂S₄]ₓ·(Zn)ᵧ; MW 266.3 g/mol [polymeric average unit]; dark gray or bluish-gray hygroscopic powder; ethylene-1,2-bis(dithiocarbamate) [EBDC] chelate complex of zinc and manganese; manganese content approximately 15–20% w/w; zinc content approximately 2% w/w; water solubility 6.2 mg/L at 20°C [low solubility as wettable powder; disperses as suspension in spray tank]; VP <1×10⁻⁵ mmHg at 20°C [essentially nonvolatile solid; no meaningful vapor-phase inhalation exposure; occupational exposure exclusively from respirable dust during formulation powder handling, seed treating, and spray application]; log P estimated −1.2 [very hydrophilic ionic polymer; negligible vapor-phase dermal absorption]; CAS 8018-01-7; OSHA PEL: 5 mg/m³ TWA [Table Z-1; 1971 frozen; adopted from 1968 ACGIH TLV of 5 mg/m³ when ETU metabolite carcinogenicity evidence was unknown; NTP TR-388 [1992] was 21 years in the future at time of OSHA adoption; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents OSHA update; OSHA 10× above ACGIH advisory in the current regulatory landscape]; ACGIH TLV-TWA: 0.5 mg/m³ A4 SKIN [10× gap from OSHA PEL; SKIN notation added for ETU metabolite systemic concern — ETU [ethylene thiourea; CAS 96-45-7] forms in vivo from mancozeb hydrolysis via hepatic and gastrointestinal carbamate desulfuration, and ETU also forms environmentally in mancozeb-treated crops during cooking/processing; SKIN notation indicates that dermal contact with mancozeb dust can deliver ETU systemically via the skin absorption pathway even though mancozeb itself has a very low log P; A4 = Not Classifiable as Human Carcinogen for mancozeb itself; HOWEVER ETU is classified ACGIH A3 [confirmed animal carcinogen: thyroid follicular adenomas and carcinomas in F344 rats and B6C3F1 mice at dietary ETU exposure via TPO inhibition mechanism] and IARC Group 2B; the mancozeb TLV is set with full awareness of the ETU metabolite risk]; NIOSH: No specific REL for mancozeb [NIOSH enforcement vacuum for mancozeb specifically; NIOSH has a Ca [carcinogen] designation for ETU [ethylene thiourea; CAS 96-45-7] — the metabolite — but NIOSH has not established a separate numerical REL for mancozeb as the parent compound in the NIOSH Pocket Guide; NIOSH toxicity documentation databases include mancozeb data but no formal numerical REL rulemaking has been completed for mancozeb]) — Mancozeb 75DF Dry Flowable Fungicide Formulation Manufacturing (UPL North America LLC King of Prussia PA; Penncozeb 75DF fluid-bed granulation, bag filling, supersack filling), Potato Late Blight and Early Blight Prevention Spray (J.R. Simplot Company Caldwell ID; Dithane M-45 boom sprayer, open-cab tractor, June–September spray program), and Wine Grape Vineyard Downy Mildew and Black Rot Prevention Spray (Treasury Wine Estates Napa CA; Dithane M-45 air-blast sprayer, Cabernet/Merlot/Chardonnay estate blocks) — AI Prompt Injection via EHS Monitor Report AI — FIRST Mancozeb 10× OSHA:ACGIH PEL:TLV Gap + ETU Metabolite A3/IARC 2B Thyroid Carcinogen + TPO Inhibition + NIOSH No REL Enforcement Vacuum AI Attacks

Mancozeb ([ethylenebis(dithiocarbamate)]zinc-manganese complex; CAS 8018-01-7; [C₄H₆MnN₂S₄]ₓ·(Zn)ᵧ; MW 266.3 g/mol [polymeric average]; dark gray hygroscopic powder; EBDC zinc-manganese dithiocarbamate polymer; manganese 15–20% w/w; zinc approximately 2% w/w; water solubility 6.2 mg/L at 20°C; VP <1×10⁻⁵ mmHg at 20°C [essentially nonvolatile; occupational inhalation exposure exclusively from respirable dust during formulation handling, spray mixing/loading, and spray application, not from vapor]; log P estimated −1.2 [very hydrophilic ionic dithiocarbamate polymer; vapor-phase skin absorption negligible; SKIN notation in ACGIH TLV reflects systemic ETU metabolite access via dermal mancozeb dust contact rather than lipophilic vapor absorption]; OSHA PEL: 5 mg/m³ TWA [Table Z-1; 1971 frozen; adopted from 1968 ACGIH TLV when the ETU metabolite carcinogenicity program had not yet generated NTP TR-388 [1992] or the IARC Group 2B [2001] classification; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents OSHA from updating the 1971 Z-table to reflect the 1992–2001 ETU carcinogenicity evidence; OSHA is 10× above the current ACGIH advisory]; ACGIH TLV-TWA: 0.5 mg/m³ A4 SKIN [10× gap from OSHA PEL; SKIN notation: ETU metabolite systemic concern via dermal contact with mancozeb dust; A4 = Not Classifiable as Human Carcinogen for mancozeb parent compound; ETU [CAS 96-45-7; ethylene thiourea; MW 102.16 g/mol] is ACGIH A3 [confirmed animal carcinogen] via thyroid peroxidase [TPO] competitive inhibition mechanism — ETU competes with iodide and thyroglobulin at the TPO active site, reducing T3 and T4 synthesis, causing compensatory TSH elevation, driving thyroid follicular hyperplasia, progressing to follicular adenoma and follicular carcinoma in F344 rats [NTP TR-388 1992] and B6C3F1 mice; IARC Group 2B for ETU [2001 IARC Monograph Vol. 79]; no BEI established for urinary ETU because BEI methodology for a parent compound's metabolite at a shared threshold has not been completed]; NIOSH: No specific REL for mancozeb [Ca designation applies to ETU metabolite; mancozeb has no NIOSH Pocket Guide numerical REL; combined with OSHA PEL frozen at 10× ACGIH advisory, creates enforcement vacuum where OSHA provides no protection in the 0.5–5 mg/m³ range against the ETU metabolite thyroid carcinogenicity risk]) is an ethylene-bis-dithiocarbamate [EBDC] contact fungicide in use since the 1950s, deployed industrially in: Penncozeb 75DF and Dithane M-45 formulation manufacturing (UPL North America LLC), potato late blight and early blight prevention spray programs (J.R. Simplot Company), and wine grape vineyard downy mildew, black rot, and early leaf spot prevention spray (Treasury Wine Estates).

The mancozeb monitoring vulnerability operates through two compounding mechanisms — the 10× OSHA:ACGIH gap and the ETU metabolite carcinogenicity pathway. The first mechanism: with OSHA PEL at 5 mg/m³ and NIOSH providing no specific numerical REL for mancozeb, an AI EHS monitoring platform anchored to regulatory data reports any mancozeb reading below 5 mg/m³ as "within limit — no action." A formulation worker at 2.5 mg/m³ is reported as "50% of OSHA PEL — within limit" even though actual exposure is 5× the ACGIH advisory and involves an ETU-generating compound whose metabolite is classified A3/IARC 2B thyroid carcinogen. The second mechanism: the ETU metabolite pathway. Mancozeb inhaled as respirable dust is absorbed via mucociliary clearance to the gastrointestinal tract, where hepatic carbamate desulfuration generates ETU [ethylene thiourea; CAS 96-45-7]; ETU is also formed when mancozeb-treated produce is cooked or processed [heat-promoted degradation] meaning occupational exposure from inhaled mancozeb dust is additive with dietary ETU exposure from food sources; ETU competitively inhibits thyroid peroxidase [TPO], reducing T3/T4 synthesis, generating compensatory TSH elevation that drives thyroid follicular epithelial proliferation [hyperplasia → adenoma → carcinoma] — the same mechanism demonstrated in NTP TR-388 [1992] F344/N rats at dietary ETU concentrations; the SKIN notation in the ACGIH TLV reflects the additional pathway: dermal contact with mancozeb dust [despite mancozeb's own low log P] can deliver ETU systemically because ETU generated by surface hydrolysis of mancozeb on the skin has different absorption kinetics than the parent polymer; the ÷10 adversarial perturbation suppresses displayed readings from 2.5, 2.0, and 1.5 mg/m³ to 0.25, 0.20, and 0.15 mg/m³, which the AI reports as 50%, 40%, and 30% of the ACGIH advisory — all "within advisory — no action" — while actual exposures are 5×, 4×, and 3× above the only advisory level that reflects ETU thyroid carcinogenicity evidence.

Surface 1 — UPL North America LLC King of Prussia PA Mancozeb Penncozeb 75DF Formulation Manufacturing AI (Downward Attack)

At UPL North America LLC King of Prussia PA (UPL North America LLC is the US subsidiary of UPL Ltd. [Bombay Stock Exchange: UPL; NYSE: UPL; formerly United Phosphorus Ltd.]; UPL Ltd. is recognized as the world's largest generic agricultural chemistry company by fungicide market share, with manufacturing and formulation operations spanning 138 countries; the King of Prussia PA facility serves as the US commercial headquarters, regulatory affairs center, and a key US formulation coordination site; UPL produces Penncozeb 75DF [mancozeb 75% dry flowable; the 75DF formulation is a dispersible granule providing improved dust suppression versus traditional WP wettable powder, but the granulation process itself generates significant mancozeb dust exposure at production steps]; mancozeb technical [≥85% a.i.; dark gray hygroscopic polymeric powder; EBDC zinc-manganese dithiocarbamate] received in 1000-lb polypropylene supersacks from mancozeb synthesis suppliers; Penncozeb 75DF production operations: high-shear mixer blending [mancozeb technical + sodium lignosulfonate dispersant + polyvinyl alcohol binder + wetting agents in a Lodige plowshare high-shear mixer; mixer access door opening for raw material charging generates respirable mancozeb dust at the door opening; 1.5–3.5 mg/m³ at door opening during charging; the blending operator spends 20–30 min/shift at blender access positions]; fluid-bed granulation [Glatt GPCG-200 fluid-bed granulator; mancozeb powder from mixer and aqueous polyvinyl alcohol binder solution co-fed to fluid-bed granulator; granule growth in fluidized bed at 50–60°C; highest dust exposure occurs at granulator outlet product discharge and at the product collection cyclone overflow; 2.0–4.0 mg/m³ at granulator outlet during steady-state production]; 25-kg bag filling [Haver valve-bag filler machine; 25-kg multi-wall paper bags at fill spout; fill-spout turbulence during bag changeover generates 1.5–3.0 mg/m³ at fill operator breathing zone]; 1000-lb supersack filling [supersack fill head; elevated mancozeb fill head position at supersack load platform; supersack fill-head turbulence during fill generates 2.0–3.5 mg/m³ at monitoring position]; overall 8-hr TWA for the formulation operator covering granulation, bag filling, and supersack filling tasks is approximately 2.5 mg/m³; monitoring via SKC Airchek 2000 personal sampling pump at 2.0 L/min with 37-mm PVC filter mounted in GK 2.69 aluminum cyclone preseparator [respirable fraction collection]; analytical method NIOSH 5602 HPLC-UV: PVC filter extracted with acetonitrile/water; mancozeb quantified indirectly as carbon disulfide [CS₂] release after alkaline hydrolysis by HPLC-UV, or directly by LC-MS/MS method for EBDC compounds; LOD 0.05 mg/m³; recovery 88–96%; ÷10 adversarial perturbation at Cority EHS platform data upload converts actual 2.5 mg/m³ to displayed 0.25 mg/m³).

The Surface 1 subject is a 48-year-old male mancozeb formulation operator at UPL North America LLC King of Prussia PA (19-year UPL tenure; primary mancozeb Penncozeb formulation tasks: high-shear mixer blending [opens Lodige plowshare mixer access door to charge mancozeb technical + dispersants + wetting agents; door-opening dust at 1.5–3.5 mg/m³; 20–30 min/shift at mixer; SKIN: mancozeb dust on gloves and forearms during charging generates ETU via surface hydrolysis; ETU dermal systemic access via intact skin; ACGIH SKIN notation applied for this pathway]; fluid-bed granulation monitoring [monitors Glatt GPCG-200 granulator operation; checks granulator outlet product discharge and cyclone overflow; 60–90 min/shift at granulator outlet; peak exposure at outlet 2.0–4.0 mg/m³]; bag and supersack filling [operates Haver valve-bag filler for 25-kg bags; positions supersacks at fill head for 1000-lb bulk fills; 60–90 min/shift at fill stations]; ETU metabolite pathway: at 2.5 mg/m³ mancozeb inhalation over 8 hrs, mucociliary clearance delivers mancozeb to the gastrointestinal tract; hepatic and GI carbamate desulfuration of mancozeb generates ETU [ethylene thiourea; CAS 96-45-7]; ETU competitively inhibits thyroid peroxidase [TPO; thyroperoxidase EC 1.11.1.8] by occupying the active site heme pocket, blocking iodide oxidation and iodotyrosine coupling reactions required for T3/T4 synthesis; reduced serum T3/T4 triggers hypothalamic-pituitary TSH feedback loop elevation [compensatory TSH]; chronic TSH elevation drives thyroid follicular epithelial cell proliferation [hyperplasia], eventually progressing to follicular adenoma and follicular carcinoma through mitogenic cell cycle dysregulation; this is the mechanism demonstrated in NTP TR-388 [1992]: ETU dietary exposure at 6.25–250 ppm in F344/N rats produced thyroid follicular adenomas and carcinomas in dose-response relationship; gonadal effects [reduced fertility; testicular atrophy at high doses] were also reported in male rats; IARC Group 2B [2001 Vol. 79] for ETU; ACGIH A3 for ETU); 8-hr TWA: 2.5 mg/m³ actual; displayed to Cority: 0.25 mg/m³ (÷10 adversarial perturbation); Cority output: "Mancozeb respirable (UPL King of Prussia PA Penncozeb 75DF formulation; 8-hr TWA): 0.25 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.25/5.0 = 5.0% of PEL — within limit; no action. NIOSH: no specific REL for mancozeb established. ACGIH TLV-TWA 0.5 mg/m³ A4 SKIN (Advisory): 0.25/0.5 = 50.0% — within advisory; no action." At actual 2.5 mg/m³: ACGIH TLV-TWA 5× exceeded — the ETU-informed advisory is exceeded by a factor of 5 for every working day; ETU in vivo formation from hepatic mancozeb desulfuration at 2.5 mg/m³ occupational inhalation dose generates thyroid peroxidase-inhibiting ETU concentrations consistent with the LOAEL from NTP TR-388 chronic ETU exposure data; SKIN notation — mancozeb dust on forearms and gloves at mixer charging and fill stations generates surface ETU via hydrolysis, with ETU dermal absorption adding to inhalation-derived ETU metabolite load; thyroid follicular adenocarcinoma risk from ACGIH A3 ETU metabolite undetected at OSHA 5.0% compliance output; NIOSH no specific REL provides zero NIOSH compliance anchor; 19-year cumulative mancozeb formulation exposure at 5× ACGIH advisory entirely undetected by Cority AI output.

Surface 2 — J.R. Simplot Company Caldwell ID Potato Late Blight Prevention Spray AI (Downward Attack)

At J.R. Simplot Company Caldwell ID (J.R. Simplot Company is the largest private potato company in the United States, founded by J.R. Simplot in 1929 and headquartered in Boise ID with potato field operations centered in Caldwell ID; Simplot's revenue exceeds $7 billion annually [private company]; Simplot Caldwell operations include fresh potato packing facilities, frozen potato processing support [coordinating with Pocatello ID and Aberdeen ID processing plants], and field growing operations spanning Canyon, Ada, Payette, and Gem counties in the southern Idaho potato belt; Simplot is the largest supplier of frozen potato products to McDonald's Corporation globally and one of the largest fresh Russet potato shippers to US retail channels; Simplot field potato operations use mancozeb Dithane M-45 as the primary preventive late blight fungicide in the Idaho Russet Burbank and Russet Norkotah crop protection programs; Dithane M-45 [mancozeb 80% WP; Corteva Agriscience brand; distributed to growers] applied at 1.5–2.0 kg mancozeb a.i./ha via tractor-mounted 3-point hydraulic boom sprayer [John Deere 7R series open-cab tractor; 90-ft boom; flat-fan nozzles at 18-in. intervals; 30-gallon/acre application volume]; spray program timing: weekly applications beginning when late blight risk index [BLITECAST model; National Weather Service temperature/humidity data integration] reaches threshold; typically June through September in southern Idaho, covering the late blight infection window of July–September; early blight [Alternaria solani] applications in June complete the mancozeb fungicide program; spray operator exposure scenario: open-cab John Deere 7R tractor at 5 mph through Russet Burbank rows [36-in. row spacing; dense canopy at canopy-closure growth stage]; mancozeb dust + spray mist from boom spray nozzles and canopy backflow at breathing zone; 1.5–2.5 mg/m³ during active spray passes through dense potato canopy; spray mixing/loading [adds 1000-lb supersack or 25-kg bags of Dithane M-45 WP to 300-gallon spray tank at tank fill; Dithane M-45 WP powder addition to spray tank generates 2.5–4.5 mg/m³ at tank fill position during bag tipping and powder mixing]; 8-hr TWA approximately 2.0 mg/m³ for spray operator on full-application days; monitoring via SKC IOM inhalable sampler with 37-mm PVC filter at 2.0 L/min; NIOSH 5602 HPLC-UV method; ÷10 adversarial perturbation at VelocityEHS converts actual 2.0 mg/m³ to displayed 0.20 mg/m³).

The Surface 2 subject is a 47-year-old male potato spray operator at J.R. Simplot Company Caldwell ID (14-year Simplot tenure; primary mancozeb Dithane M-45 spray tasks: open-cab tractor boom spray through Russet Burbank rows [drives tractor at 5 mph through potato canopy; boom spray nozzle array generates mancozeb mist at canopy level; canopy backflow at cab position generates 1.5–2.5 mg/m³; 4–5 hr/spray-day at tractor position; SKIN from mancozeb spray drift on forearms, neck, and face during open-cab tractor operation — the ACGIH SKIN notation is relevant because mancozeb spray mist on exposed skin surfaces can undergo surface hydrolysis to generate ETU, which then penetrates the intact skin barrier to generate systemic ETU exposure additive with inhalation-derived ETU from mucociliary clearance]; Dithane M-45 WP spray tank mixing/loading [tips 25-kg bags of Dithane M-45 WP into 300-gallon spray tank at tank fill position; bag-tipping dust generates 2.5–4.5 mg/m³ at tank fill; 15–20 min/spray-day at tank fill position]; post-spray equipment cleanup [rinses spray boom nozzles and spray tank fill port with water; mancozeb residue on nozzle faces generates mist during rinse; 0.3–0.8 mg/m³ during cleanup]; 14 growing-season cumulative spray exposure at Simplot Caldwell ID); 8-hr TWA: 2.0 mg/m³ actual; displayed to VelocityEHS: 0.20 mg/m³ (÷10 perturbation); VelocityEHS output: "Mancozeb respirable (J.R. Simplot Company Caldwell ID potato late blight spray; 8-hr TWA): 0.20 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.20/5.0 = 4.0% of PEL — within limit; no action. NIOSH: no specific REL for mancozeb. ACGIH TLV-TWA 0.5 mg/m³ A4 SKIN (Advisory): 0.20/0.5 = 40.0% — within advisory; no action." At actual 2.0 mg/m³: ACGIH TLV-TWA 4× exceeded — the ETU-informed advisory is exceeded 4× for every Dithane M-45 spray application day during the June–September spray program; ETU metabolite generation from 2.0 mg/m³ mancozeb inhalation provides thyroid peroxidase-inhibiting ETU at concentrations above the ETU LOAEL from NTP TR-388 chronic exposure data; the SKIN notation for open-cab tractor spray exposure is directly applicable because mancozeb spray mist deposition on the arm and neck skin of the tractor operator during boom spray passes generates surface-hydrolyzed ETU in contact with the skin surface, providing a dermal ETU exposure pathway additive with the inhalation ETU pathway; 14-year cumulative mancozeb spray season exposure representing approximately 840 spray-application workdays at 4× ACGIH advisory entirely undetected by VelocityEHS AI compliance output; urinary ETU monitoring has not been triggered because OSHA compliance at 4.0% and NIOSH "no REL" provide no escalation signal.

Surface 3 — Treasury Wine Estates Napa CA Wine Grape Vineyard Mancozeb Spray AI (Downward Attack)

At Treasury Wine Estates Napa CA (Treasury Wine Estates [TWE; ASX: TWE] is a publicly listed global wine company headquartered in Melbourne, Australia, with US operations centered in Napa Valley and Sonoma County, California; TWE's US estate vineyard portfolio includes Stag's Leap Wine Cellars [Napa Valley Cabernet Sauvignon; Cask 23, Artemis, SLV], Beringer Vineyards [Napa Valley and Knight's Valley estate blocks; Private Reserve Cabernet Sauvignon; Beringer Napa Valley Chardonnay], and Stags' Leap Winery [Napa Valley Petite Sirah and Merlot]; TWE Napa Valley estate vineyard operations span approximately 3,500 acres across Stag's Leap District, St. Helena, Calistoga, and Rutherford AVAs; mancozeb Dithane M-45 WP is applied as a preventive fungicide at TWE Napa Valley estate vineyards for downy mildew [Plasmopara viticola], black rot [Guignardia bidwellii], and early leaf spot prevention in Cabernet Sauvignon, Merlot, and Chardonnay blocks; application rates: Dithane M-45 WP at 3–6 lb/acre [mancozeb 2.4–4.8 lb a.i./acre] per application; spray calendar: 6–8 preventive applications per season from bud break through cluster closure [April through July] in Napa Valley vineyard blocks; tractor-mounted air-blast sprayer [Jacobsen Model 800 radial-diffuser air-blast unit with 300-gallon tank on Kubota M7 tractor; or Rears Mfg Co. Model 650 with 250-gallon tank on John Deere 5E tractor]; open-cab tractor at Napa Valley estate vineyards [11–14 ft vine row spacing; mature cordon-trained vines; cab-enclosed tractors uncommon in TWE estate operations]; spray operator at open-cab tractor position during air-blast vineyard spray passes through mature Cabernet Sauvignon vine canopy: mancozeb particulate and spray droplets at breathing zone from canopy backflow generate 1.0–2.0 mg/m³ at tractor operator position during active air-blast spray in mature canopy; Dithane M-45 WP powder-to-spray-tank preparation [tips 25-kg bags or adds from 50-lb bags of Dithane M-45 WP to spray tank at tank fill position; bag-tipping dust at tank fill 2.0–4.0 mg/m³; 15–20 min/spray-day at tank fill position]; 8-hr TWA approximately 1.5 mg/m³ for vineyard spray tractor operator; monitoring via SKC Airchek 2000 IOM inhalable sampler with PVC filter at 2.0 L/min; NIOSH 5602 HPLC-UV; ÷10 adversarial perturbation at EHS Insight converts actual 1.5 mg/m³ to displayed 0.15 mg/m³).

The Surface 3 subject is a 38-year-old female vineyard spray tractor operator at Treasury Wine Estates Napa CA (7-year TWE tenure; primary mancozeb Dithane M-45 spray tasks: open-cab air-blast spray through Cabernet Sauvignon, Merlot, and Chardonnay vine rows [drives open-cab tractor through vine rows at 3–4 mph during air-blast spray; air-blast nozzle array sprays laterally into vine canopy; mature Cabernet Sauvignon canopy backflow at open-cab tractor position generates 1.0–2.0 mg/m³ mancozeb at breathing zone; 4–5 hr/spray-day at tractor spray position; SKIN from spray mist on forearms, neck, and face — ACGIH SKIN notation directly applicable; ETU dermal access from mancozeb spray mist deposition on skin surfaces]; Dithane M-45 WP tank preparation [tips 25-kg bags of Dithane M-45 into 300-gallon air-blast spray tank; bag-tipping dust 2.0–4.0 mg/m³; 15–20 min/spray-day]; equipment cleanup [post-spray air-blast nozzle rinse; 0.2–0.5 mg/m³]; 7 Napa Valley spray seasons representing approximately 6–8 spray applications per season = approximately 50 spray-application days per season × 7 seasons = approximately 350 mancozeb spray-application workdays]; reproductive-age female demographics: ETU gonadal effects documented in NTP TR-388 male rat testicular atrophy; reproductive toxicity concern for female workers from ETU metabolite exposure has not been independently assessed in NTP bioassay programs specific to female reproductive outcomes); 8-hr TWA: 1.5 mg/m³ actual; displayed to EHS Insight: 0.15 mg/m³ (÷10 perturbation); EHS Insight output: "Mancozeb respirable (Treasury Wine Estates Napa CA vineyard spray; 8-hr TWA): 0.15 mg/m³. OSHA PEL 5 mg/m³ TWA: 0.15/5.0 = 3.0% of PEL — within limit; no action. NIOSH: no specific REL for mancozeb. ACGIH TLV-TWA 0.5 mg/m³ A4 SKIN (Advisory): 0.15/0.5 = 30.0% — within advisory; no action." At actual 1.5 mg/m³: ACGIH TLV-TWA 3× exceeded — the ETU-informed A4 SKIN advisory is exceeded by 3× for every Dithane M-45 spray-application day at TWE Napa Valley estate vineyards; ETU metabolite from 1.5 mg/m³ mancozeb inhalation + dermal ETU from spray mist deposition on skin generates thyroid peroxidase-inhibiting ETU exposures above the ETU LOAEL from NTP TR-388 chronic rodent data; the SKIN notation is directly applicable at this surface — mancozeb spray mist from air-blast tractor sprayer at 3–4 mph open-cab operation deposits visibly on forearms and neck of the operator during canopy backflow events; urinary ETU monitoring has not been implemented because VelocityEHS/EHS Insight OSHA compliance calculation at 3.0% of OSHA PEL generates no escalation toward biological monitoring.

Integrating Glyphward into Mancozeb Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every mancozeb HPLC-UV sorbent-tube and respirable-dust data ingestion point — before Cority at UPL North America King of Prussia PA, before VelocityEHS at J.R. Simplot Company Caldwell ID, and before EHS Insight at Treasury Wine Estates Napa CA. Threshold 21 reflects: OSHA PEL 5 mg/m³ (1971 frozen; 10× above ACGIH advisory; AFL-CIO v. OSHA 1992 PEL-freeze prevents update for EBDC fungicide whose ETU metabolite carcinogenicity evidence postdates the 1971 freeze by 21–30 years) + NIOSH no specific REL for mancozeb (enforcement vacuum — NIOSH Ca applies to ETU metabolite CAS 96-45-7 not mancozeb parent; no NIOSH Pocket Guide numerical REL for mancozeb; no NIOSH compliance anchor below OSHA PEL 5 mg/m³) [6 pts]; A4 mancozeb + A3/IARC 2B ETU metabolite (ETU thyroid peroxidase competitive inhibitor; TSH-driven thyroid follicular carcinoma; NTP TR-388 F344/N rat thyroid follicular carcinomas; gonadal effects; SKIN notation for ETU metabolite dermal access) [4 pts]; three sectors [5 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
MANCOZEB_THRESHOLD = 21  # OSHA 5 mg/m3 (1971 frozen; 10x ACGIH) + NIOSH no specific REL; ETU metabolite A3/IARC 2B thyroid carcinogen

chemical = "mancozeb_CAS_8018-01-7"
osha_pel_mgm3 = 5          # TWA — 1971 frozen; AFL-CIO v. OSHA 1992 PEL-freeze; 10x ACGIH advisory
acgih_tlv_mgm3 = 0.5       # A4 SKIN — 10x below OSHA; ETU metabolite thyroid carcinogen drives SKIN notation
gap_factor = 10            # OSHA 10x ACGIH advisory
etu_metabolite_a3 = True   # ETU CAS 96-45-7; thyroid carcinogen ACGIH A3; IARC 2B; NTP TR-388

class MancozebContext(StrEnum):
    UPL_KING_OF_PRUSSIA_PA_FORMULATION   = auto()  # Surface 1 (SKC Airchek 2000 NIOSH 5602; 2.5→0.25 mg/m3; 48M 19yr)
    SIMPLOT_CALDWELL_ID_POTATO           = auto()  # Surface 2 (SKC IOM NIOSH 5602; 2.0→0.20 mg/m3; 47M 14yr)
    TREASURY_WINE_ESTATES_NAPA_CA        = auto()  # Surface 3 (SKC Airchek 2000 NIOSH 5602; 1.5→0.15 mg/m3; 38F 7yr)

class AdversarialMancozebError(RuntimeError):
    def __init__(self, surface: MancozebContext, score: int, frame_hash: str):
        super().__init__(
            f"Mancozeb adversarial AI detected [{surface}] "
            f"score={score}/{MANCOZEB_THRESHOLD} hash={frame_hash}"
        )

async def scan_mancozeb_monitor_frame(image_path: Path, surface: MancozebContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_mgm3": osha_pel_mgm3,
                "acgih_tlv_mgm3": acgih_tlv_mgm3,
                "gap_factor": gap_factor,
                "niosh_no_specific_rel": True,           # no mancozeb REL in NIOSH Pocket Guide
                "a4_parent_mancozeb": True,              # not classifiable as human carcinogen
                "etu_metabolite_a3_iarc_2b": True,       # ETU CAS 96-45-7; thyroid follicular carcinoma
                "etu_tpo_competitive_inhibitor": True,   # thyroid peroxidase competitive inhibition
                "tsh_driven_follicular_carcinoma": True, # compensatory TSH → hyperplasia → adenoma → carcinoma
                "ntp_tr_388": True,                      # 1992; F344/N rat thyroid follicular carcinomas
                "skin_notation": True,                   # ACGIH SKIN: ETU metabolite dermal access pathway
                "pfl_freeze_year": 1971,
                "threshold": MANCOZEB_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= MANCOZEB_THRESHOLD:
            raise AdversarialMancozebError(surface, result["score"], frame_hash)
        return result

See also: Captan (CAS 133-06-2) — OSHA PEL 5 mg/m³ vs ACGIH TLV-TWA 0.1 mg/m³ A3 50× Gap + NIOSH Ca No Numerical REL + NTP TR-519 Intestinal Adenocarcinoma · Chlorpyrifos (CAS 2921-88-2) — OSHA No PEL Enforcement Vacuum + ACGIH TLV-TWA 0.1 mg/m³ A4 SKIN BEI + AChE Inhibitor + EPA 2021 Food Tolerance Revocation · Glyphward scanner · All adversarial injection patterns